DENA CROSSER: Open Payments
NPI 1740695014 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 53 payments from 18 companies in 2025. Trend: 2023 $316 · 2024 $369 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $175 |
| AstraZeneca Pharmaceuticals LP | 7 | $165 |
| Lilly USA, LLC | 9 | $133 |
| PFIZER INC. | 4 | $82 |
| ABBVIE INC. | 2 | $45 |
| Corcept Therapeutics | 2 | $44 |
| Abbott Laboratories | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $34 |
| Dexcom, Inc. | 1 | $32 |
Products named: Ozempic, NURTEC ODT, MOUNJARO, FARXIGA, JARDIANCE, AIRSUPRA, BREZTRI, UBRELVY.
Industry payments across OH — which companies pay providers there.
